One of the punching bags of the ASX, Lumos Diagnostics (ASX: LDX), which develops diagnostics for healthcare professionals to more…
While small cap shareholders have become accustomed to major share price gains once a medtech or biotech receives FDA approval…
Rapid antigen tests (or lack thereof) have dominated the headlines for months now. Turning your kitchen counter into a mini…
With 'Rapid Antigen Test' having only taken several days to likely be one of the most commonly used words of…
Having secured approval from regulators in Canada last month, Lumos Diagnostics (ASX: LDX) is set to dispatch the first orders…
With ever increasing bodies of medical research and demand for early disease detection climbing, it's high time that we rethink…